Extensive subpial cortical demyelination is specific to multiple sclerosis. (3rd February 2020)

• Record Type: Journal Article
• Authors: Junker, Andreas; Wozniak, Jadwiga; Voigt, David; Scheidt, Uta; Antel, Jack; Wegner, Christiane; Brück, Wolfgang; Stadelmann, Christine
• Is Part Of: Brain pathology. Volume 30:Number 3(2020)
• Page Start: 641
• Page End: 652
• Publication Date: 2020-02-03
• Subjects: multiple sclerosis (MS) -- progressive multifocal leukoencephalopathy (PML) -- cortical demyelination -- subpial lesions -- meningitis -- carcinomatous and lymphomatous meningitis -- neuromyelitis optica (NMO) -- acute disseminated encephalomyelitis (ADEM) -- oxidative stress; Nervous system -- Diseases -- Periodicals; Brain -- Diseases -- Periodicals; Neurology -- Periodicals; Brain Diseases -- Periodicals; Cerveau -- Maladies -- Périodiques; Système nerveux -- Maladies -- Périodiques; Neurologie -- Périodiques; 616.805
• DOI: 10.1111/bpa.12813
• Languages: English
• ISSNs: 1015-6305

Abstract

Abstract: Cortical demyelinated lesions are frequent and widespread in chronic multiple sclerosis (MS) patients, and may contribute to disease progression. Inflammation and related oxidative stress have been proposed as central mediators of cortical damage, yet meningeal and cortical inflammation is not specific to MS, but also occurs in other diseases. The first aim of this study was to test whether cortical demyelination was specific for demyelinating CNS diseases compared to other CNS disorders with prominent meningeal and cortical inflammation. The second aim was to assess whether oxidative tissue damage was associated with the extent of neuroaxonal damage. We studied a large cohort of patients diagnosed with demyelinating CNS diseases and non‐demyelinating diseases of autoimmune, infectious, neoplastic or metabolic origin affecting the meninges and the cortex. Included were patients with MS, acute disseminated encephalomyelitis (ADEM), neuromyelitis optica (NMO), viral and bacterial meningoencephalitis, progressive multifocal leukoencephalopathy (PML), subacute sclerosing panencephalitis (SSPE), carcinomatous and lymphomatous meningitis and metabolic disorders such as extrapontine myelinolysis, thus encompassing a wide range of adaptive and innate cytokine signatures. Using myelin protein immunohistochemistry, we found cortical demyelination in MS, ADEM, PML and extrapontine myelinolysis, whereby each condition showed a disease‐specific histopathological pattern. Remarkably, extensive ribbon‐like subpial demyelination was only observed in MS, thus providing an important pathogenetic and diagnostic cue. Cortical oxidative injury was detected in both demyelinating and non‐demyelinating CNS disorders. Our data demonstrate that meningeal and cortical inflammation alone accompanied by oxidative stress are not sufficient to generate the extensive subpial cortical demyelination found in MS, but require other MS‐specific factors.